Paradigm Biocapital Advisors LP - OYSTER PT PHARMA INC ownership

OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 80 filers reported holding OYSTER PT PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of OYSTER PT PHARMA INC
ValueSharesWeighting
Q3 2022$9,264,000
+60.5%
1,648,316
+23.6%
1.24%
+7.3%
Q2 2022$5,773,000
-49.8%
1,333,330
+35.0%
1.15%
-62.1%
Q1 2022$11,497,000
+107.0%
987,698
+224.6%
3.04%
+91.7%
Q4 2021$5,555,000304,2381.59%
Other shareholders
OYSTER PT PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 2,768,586$32,226,00014.34%
Paradigm Biocapital Advisors LP 987,698$11,497,0003.04%
NEA Management Company, LLC 5,925,287$68,970,0001.99%
KPCB XIV Associates, LLC 367,987$4,283,0001.61%
Telemark Asset Management, LLC 787,026$9,161,0000.81%
COWEN AND COMPANY, LLC 509,794$5,934,0000.57%
RTW INVESTMENTS, LP 2,058,504$23,961,0000.50%
ACT CAPITAL MANAGEMENT, LLC 13,500$157,0000.17%
Kohlberg Kravis Roberts & Co. L.P. 1,039,622$12,101,0000.11%
Wildcat Capital Management, LLC 36,847$429,0000.11%
View complete list of OYSTER PT PHARMA INC shareholders